The pathophysiology and diagnosis of orthostatic hypotension

@article{Robertson2007ThePA,
  title={The pathophysiology and diagnosis of orthostatic hypotension},
  author={David Robertson},
  journal={Clinical Autonomic Research},
  year={2007},
  volume={18},
  pages={2-7}
}
  • D. Robertson
  • Published 27 March 2008
  • Medicine
  • Clinical Autonomic Research
Orthostatic Hypotension (OH) is a common manifestation of blood pressure dysregulation. OH takes a heavy toll on quality of life. It has many potential etiologies, and many effects of aging can increase susceptibility to OH. Neurological disorders are especially likely to cause severe OH. In this brief review, the pathogenesis of OH is considered, particularly in terms of autonomic neuropathy, multiple system atrophy (MSA), pure autonomic failure, baroreflex failure, and dopamine beta… 

Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management

An overview of the clinical presentation, pathophysiology, epidemiology, evaluation and management of neurogenic orthostatic hypotension focusing on neurodegenerative disorders is provided.

Management of neurogenic orthostatic hypotension.

Morbidity and mortality of orthostatic hypotension: implications for management of cardiovascular disease.

This review provides an overview of the current information on this topic and recommends the more frequent assessment of OH in clinical practice and in future clinical trials.

Orthostatic Hypotension: Epidemiology, Prognosis, and Treatment.

Pharmacologic treatment of orthostatic hypotension

Management of Neurogenic Orthostatic Hypotension in Patients with Autonomic Failure

Treatment options for neurogenic orthostatic hypotension are reviewed and an algorithm for its management is included that emphasizes the importance of non-pharmacologic measures and provides guidance on pharmacologic treatment options.

Neurogenic Orthostatic Hypotension. Lessons From Synucleinopathies.

Treatment for NOH is to improve quality of life and prevent syncope and falls by reducing symptoms of cerebral hypoperfusion, and drugs that enhance residual sympathetic tone are more effective in patients with mild disease and in MSA patients with spared postganglionic fibers.

Syndromes of orthostatic intolerance: a hidden danger

Future studies of OH should focus on mechanisms that lead to neurogenic and nonneurogenic OH, novel diagnostic methods and more effective therapeutic modalities, as well as on management of symptomatic orthostatic intolerance.

Review of management strategies for orthostatic hypotension in older people

In this review, the current evidence for existing and emerging treatments for OH is presented, and the management of supine hypertension associated with the treatment of OH in patients with autonomic failure is addressed.

Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer

The pathophysiology and effects of Neurogenic orthostatic hypotension, a potentially serious manifestation of cardiovascular sympathetic failure that occurs in approximately 30% of patients with PD, are reviewed.
...

References

SHOWING 1-10 OF 29 REFERENCES

Management of chronic orthostatic hypotension.

Postural tachycardia syndrome (POTS).

A system that grades the severity of orthostatic intolerance by the three-pronged criteria of the rapidity of development and the severe symptoms, the ability of the subject to withstand Orthostatic stresses, and the degree of interference with daily living is presented.

l-DOPS therapy for refractory orthostatic hypotension in autoimmune autonomic neuropathy

Addition of l-threo-3,4-dihidroxyphenylserine (l-DOPS) substantially improved blood pressure and orthostatic tolerance and be particularly effective in patients with ganglionic NiAchR antibodies.

Orthostatic hypertension: when pressor reflexes overcompensate

Orthostatic hypertension—a rise in blood pressure upon assuming upright posture—is an underappreciated and understudied clinical phenomenon. There is currently no widely agreed-upon definition of

Syncope in the elderly.

Therapy should be directed toward preventing recurrent episodes by minimizing risks for syncope and treating symptomatic abnormalities regardless of the age of the patient, but with attention to age-related changes in drug metabolism and action.

Delayed orthostatic hypotension

Delayed orthostatic hypotension occurred in 54% of the tested population and was associated with milder abnormalities of sympathetic Adrenergic function, suggesting this disorder may be a mild or early form of sympathetic adrenergic failure.

Initial orthostatic hypotension: review of a forgotten condition.

This review alerts clinicians and clinician scientists to a common, yet often neglected, condition that occurs only upon an active change of posture and discusses its epidemiology, pathophysiology and management.

The nature of the autonomic dysfunction in multiple system atrophy

Postural Tachycardia Syndrome (POTS)

Postural Tachycardia Syndrome is defined as the development of orthostatic symptoms associated with a heart rate increment ≥30, usually to ≥120 bpm without orthostasis hypotension.

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy

A Consensus Confe rence was convened on 16 November 1995 in Phoenix, Arizona, USA with the specific aim of generating a consensus on three specific items: the definition of orthostatic hypotension,